Trial Outcomes & Findings for Mindfulness-Based Intervention for Depression and Insulin Resistance in Adolescents (NCT NCT04992299)

NCT ID: NCT04992299

Last Updated: 2026-04-02

Results Overview

Facilitators score ≥8 on adherence and competence ratings of MBI, CBT, and HealthEd adolescent group sessions (1=poor to 10=exceptional)

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

120 participants

Primary outcome timeframe

12-months

Results posted on

2026-04-02

Participant Flow

The first participant was enrolled on May 5, 2022, and enrollment was completed for this trial on September 9, 2023.

994 phone pre-screens were initiated. 160 of these were estimated to be eligible and proceeded to the screening phase. Of these, 22 were determined to be ineligible and 18 either did not complete the screening process or declined to continue in the study prior to randomization.

Participant milestones

Participant milestones
Measure
Mindfulness-Based Intervention
6-week group intervention, Learning to BREATHE, an adolescent mindfulness-based intervention derived from mindfulness-based stress reduction
Cognitive-Behavioral Therapy
6-week group intervention, the Blues Program, a cognitive-behavioral intervention for adolescents with elevated symptoms of depression
Health Education
6-week group program providing didactic information on adolescent health topics
Overall Study
STARTED
37
43
40
Overall Study
COMPLETED
31
31
38
Overall Study
NOT COMPLETED
6
12
2

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Mindfulness-Based Intervention for Depression and Insulin Resistance in Adolescents

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Mindfulness-Based Intervention
n=37 Participants
6-week group intervention, Learning to BREATHE, an adolescent mindfulness-based intervention derived from mindfulness-based stress reduction
Cognitive-Behavioral Therapy
n=43 Participants
6-week group intervention, the Blues Program, a cognitive-behavioral intervention for adolescents with elevated symptoms of depression
Health Education
n=40 Participants
6-week group program providing didactic information on adolescent health topics
Total
n=120 Participants
Total of all reporting groups
Age, Categorical
<=18 years
37 Participants
n=5 Participants
43 Participants
n=5 Participants
40 Participants
n=10 Participants
120 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
0 Participants
n=5 Participants
0 Participants
n=10 Participants
0 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=5 Participants
0 Participants
n=10 Participants
0 Participants
n=5 Participants
Sex: Female, Male
Female
22 Participants
n=5 Participants
25 Participants
n=5 Participants
23 Participants
n=10 Participants
70 Participants
n=5 Participants
Sex: Female, Male
Male
15 Participants
n=5 Participants
18 Participants
n=5 Participants
17 Participants
n=10 Participants
50 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
17 Participants
n=5 Participants
19 Participants
n=5 Participants
18 Participants
n=10 Participants
54 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
20 Participants
n=5 Participants
24 Participants
n=5 Participants
22 Participants
n=10 Participants
66 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=5 Participants
0 Participants
n=10 Participants
0 Participants
n=5 Participants
BMI Status
Overweight BMI 85-94th percentile
9 Participants
n=5 Participants
7 Participants
n=5 Participants
7 Participants
n=10 Participants
23 Participants
n=5 Participants
BMI Status
Obesity BMI >=95th percentile
28 Participants
n=5 Participants
36 Participants
n=5 Participants
33 Participants
n=10 Participants
97 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 12-months

Population: 49 total sessions were rated by experts, about 1/3 of randomly selected sessions across arms; facilitators were not considered enrolled but contributed to this assessment

Facilitators score ≥8 on adherence and competence ratings of MBI, CBT, and HealthEd adolescent group sessions (1=poor to 10=exceptional)

Outcome measures

Outcome measures
Measure
Health Education
n=17 GroupSession
6-week group program providing didactic information on adolescent health topics
Mindfulness-Based Intervention
n=14 GroupSession
6-week group intervention, Learning to BREATHE, an adolescent mindfulness-based intervention derived from mindfulness-based stress reduction
Cognitive-Behavioral Therapy
n=18 GroupSession
6-week group intervention, the Blues Program, a cognitive-behavioral intervention for adolescents with elevated symptoms of depression
Intervention Fidelity
Facilitator Adherence
96 Expert ratings ranging from 0-100%
Interval 90.0 to 100.0
100 Expert ratings ranging from 0-100%
Interval 95.0 to 100.0
90.5 Expert ratings ranging from 0-100%
Interval 90.0 to 92.5
Intervention Fidelity
Facilitator Competence
97.5 Expert ratings ranging from 0-100%
Interval 90.0 to 100.0
90 Expert ratings ranging from 0-100%
Interval 80.0 to 100.0
90 Expert ratings ranging from 0-100%
Interval 80.0 to 92.5

PRIMARY outcome

Timeframe: 12-months

Population: 138 is the number of participants who were determined to be eligible or possibly eligible after starting the screening/baseline assessment phase; 120 out of 138=87%

≥80% eligible adolescents will enroll

Outcome measures

Outcome measures
Measure
Health Education
6-week group program providing didactic information on adolescent health topics
Mindfulness-Based Intervention
n=138 Participants
6-week group intervention, Learning to BREATHE, an adolescent mindfulness-based intervention derived from mindfulness-based stress reduction
Cognitive-Behavioral Therapy
6-week group intervention, the Blues Program, a cognitive-behavioral intervention for adolescents with elevated symptoms of depression
Recruitment Feasibility: Percentage of Eligible Adolescents Who Enroll
120 Number who chose to enroll

SECONDARY outcome

Timeframe: 6-months

Population: Number of facilitators who were trained in each intervention type, who scored at least 80% or higher on post-training knowledge test; facilitators were not considered enrolled but contributed to this assessment

Facilitators score ≥80% on post-training knowledge/ competency tests of MBI, CBT, and HealthEd

Outcome measures

Outcome measures
Measure
Health Education
n=9 Participants
6-week group program providing didactic information on adolescent health topics
Mindfulness-Based Intervention
n=11 Participants
6-week group intervention, Learning to BREATHE, an adolescent mindfulness-based intervention derived from mindfulness-based stress reduction
Cognitive-Behavioral Therapy
n=10 Participants
6-week group intervention, the Blues Program, a cognitive-behavioral intervention for adolescents with elevated symptoms of depression
Training Fidelity: Facilitator Knowledge After Training
9 Participants
11 Participants
10 Participants

SECONDARY outcome

Timeframe: 6-months

Population: Facilitators were not considered enrolled but contributed to this assessment; facilitators were not considered enrolled but contributed to this assessment

Facilitators score ≥8 on adherence and competence ratings of MBI, CBT, and HealthEd mock group sessions (1=poor to 10=exceptional)

Outcome measures

Outcome measures
Measure
Health Education
n=18 GroupSession
6-week group program providing didactic information on adolescent health topics
Mindfulness-Based Intervention
n=18 GroupSession
6-week group intervention, Learning to BREATHE, an adolescent mindfulness-based intervention derived from mindfulness-based stress reduction
Cognitive-Behavioral Therapy
n=18 GroupSession
6-week group intervention, the Blues Program, a cognitive-behavioral intervention for adolescents with elevated symptoms of depression
Training Fidelity: Facilitator Adherence and Competence During Mock Sessions
Facilitator Competence
82.5 Expert ratings ranging from 0-100%
Interval 80.0 to 93.8
80 Expert ratings ranging from 0-100%
Interval 80.0 to 85.0
86 Expert ratings ranging from 0-100%
Interval 85.0 to 87.5
Training Fidelity: Facilitator Adherence and Competence During Mock Sessions
Facilitator Adherence
80 Expert ratings ranging from 0-100%
Interval 80.0 to 92.0
85 Expert ratings ranging from 0-100%
Interval 80.0 to 90.0
90 Expert ratings ranging from 0-100%
Interval 90.0 to 92.0

SECONDARY outcome

Timeframe: 24-months

Population: Number of months it took to enroll the 120 target sample

Attainment of target N=120 within a 12-month period; CONSORT flow/number of months to reach recruitment goal

Outcome measures

Outcome measures
Measure
Health Education
6-week group program providing didactic information on adolescent health topics
Mindfulness-Based Intervention
n=120 Participants
6-week group intervention, Learning to BREATHE, an adolescent mindfulness-based intervention derived from mindfulness-based stress reduction
Cognitive-Behavioral Therapy
6-week group intervention, the Blues Program, a cognitive-behavioral intervention for adolescents with elevated symptoms of depression
Recruitment Feasibility
16 Months

SECONDARY outcome

Timeframe: 6-weeks

≥80% adolescents attend 5:6 (80%) group MBI/CBT/HealthEd sessions

Outcome measures

Outcome measures
Measure
Health Education
n=40 Participants
6-week group program providing didactic information on adolescent health topics
Mindfulness-Based Intervention
n=37 Participants
6-week group intervention, Learning to BREATHE, an adolescent mindfulness-based intervention derived from mindfulness-based stress reduction
Cognitive-Behavioral Therapy
n=43 Participants
6-week group intervention, the Blues Program, a cognitive-behavioral intervention for adolescents with elevated symptoms of depression
Intervention Feasibility: Attendance
30 Participants
32 Participants
31 Participants

SECONDARY outcome

Timeframe: 6-weeks

≥80% adolescent liking/credibility ratings ≥4 (1=not at all to 5=extremely)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 6-weeks

Themes indicative of acceptability of interventions, as derived from grounded theory/qualitative analysis of adolescent focus-groups at post-intervention

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 12-months

Population: Number who completed follow-up

≥80% at post-treatment follow-up and ≥70% at 1-year follow-up

Outcome measures

Outcome measures
Measure
Health Education
n=40 Participants
6-week group program providing didactic information on adolescent health topics
Mindfulness-Based Intervention
n=37 Participants
6-week group intervention, Learning to BREATHE, an adolescent mindfulness-based intervention derived from mindfulness-based stress reduction
Cognitive-Behavioral Therapy
n=43 Participants
6-week group intervention, the Blues Program, a cognitive-behavioral intervention for adolescents with elevated symptoms of depression
Retention Feasibility
6-week/post-intervention follow-up
38 Participants
35 Participants
33 Participants
Retention Feasibility
1-year follow-up
38 Participants
31 Participants
31 Participants

SECONDARY outcome

Timeframe: 18-months

≥95% accuracy on standardized protocol checklists for all assessments

Outcome measures

Outcome data not reported

Adverse Events

Health Education

Serious events: 0 serious events
Other events: 35 other events
Deaths: 0 deaths

Mindfulness-Based Intervention

Serious events: 0 serious events
Other events: 29 other events
Deaths: 0 deaths

Cognitive-Behavioral Therapy

Serious events: 1 serious events
Other events: 27 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Health Education
n=40 participants at risk
6-week group program providing didactic information on adolescent health topics
Mindfulness-Based Intervention
n=37 participants at risk
6-week group intervention, Learning to BREATHE, an adolescent mindfulness-based intervention derived from mindfulness-based stress reduction
Cognitive-Behavioral Therapy
n=43 participants at risk
6-week group intervention, the Blues Program, a cognitive-behavioral intervention for adolescents with elevated symptoms of depression
Psychiatric disorders
Hospitalization for psychological concerns
0.00%
0/40 • From baseline through end of the follow-up period, up to 1 year
All adverse events were tracked in line with standard guidelines/ClinicalTrials.gov definitions
0.00%
0/37 • From baseline through end of the follow-up period, up to 1 year
All adverse events were tracked in line with standard guidelines/ClinicalTrials.gov definitions
2.3%
1/43 • From baseline through end of the follow-up period, up to 1 year
All adverse events were tracked in line with standard guidelines/ClinicalTrials.gov definitions

Other adverse events

Other adverse events
Measure
Health Education
n=40 participants at risk
6-week group program providing didactic information on adolescent health topics
Mindfulness-Based Intervention
n=37 participants at risk
6-week group intervention, Learning to BREATHE, an adolescent mindfulness-based intervention derived from mindfulness-based stress reduction
Cognitive-Behavioral Therapy
n=43 participants at risk
6-week group intervention, the Blues Program, a cognitive-behavioral intervention for adolescents with elevated symptoms of depression
Metabolism and nutrition disorders
Elevated lab results
65.0%
26/40 • From baseline through end of the follow-up period, up to 1 year
All adverse events were tracked in line with standard guidelines/ClinicalTrials.gov definitions
51.4%
19/37 • From baseline through end of the follow-up period, up to 1 year
All adverse events were tracked in line with standard guidelines/ClinicalTrials.gov definitions
34.9%
15/43 • From baseline through end of the follow-up period, up to 1 year
All adverse events were tracked in line with standard guidelines/ClinicalTrials.gov definitions
General disorders
Elevated blood pressure at any point from baseline to 1-year follow-up
20.0%
8/40 • From baseline through end of the follow-up period, up to 1 year
All adverse events were tracked in line with standard guidelines/ClinicalTrials.gov definitions
10.8%
4/37 • From baseline through end of the follow-up period, up to 1 year
All adverse events were tracked in line with standard guidelines/ClinicalTrials.gov definitions
9.3%
4/43 • From baseline through end of the follow-up period, up to 1 year
All adverse events were tracked in line with standard guidelines/ClinicalTrials.gov definitions
Psychiatric disorders
Mental health concerns assessed at any point from baseline (within past year) to 1-year follow-up
55.0%
22/40 • From baseline through end of the follow-up period, up to 1 year
All adverse events were tracked in line with standard guidelines/ClinicalTrials.gov definitions
43.2%
16/37 • From baseline through end of the follow-up period, up to 1 year
All adverse events were tracked in line with standard guidelines/ClinicalTrials.gov definitions
39.5%
17/43 • From baseline through end of the follow-up period, up to 1 year
All adverse events were tracked in line with standard guidelines/ClinicalTrials.gov definitions

Additional Information

Lauren Shomaker

Colorado State University

Phone: 970-491-3217

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place